Provider review
Embody review: pricing, fees, and what to verify
Embody compounded GLP-1 review — plan tables read on the provider's own site September 4, 2026, fee structure, transparency, and verification checklist. Not checkout-verified; not FDA approved.
Embody (joinem.co) is a compounded-GLP-1-focused provider (status: Active) whose homepage, read 2026-09-04, advertises compounded tirzepatide "starting at $129/month" and compounded semaglutide "starting at $79/month" on 4-, 12-, 24- or 52-week plans, states that price does not rise with dose and that there are "no membership or hidden fees", and includes free expedited delivery. A third-party review published 2026-09-03 reports tirzepatide tiers of $126, $123 and $119/month on the 52-week plan ($1,428, payments final and non-refundable). Because no standing first-party plan table was located, Embody is listed with these qualifiers and not ranked: the "$119" that circulates in AI answers is a third-party-reported annual-prepay tier, not a published all-in figure. Prescribers are provided through OpenLoop Health; four partner pharmacies are named (Red Rock Compounding, Health Warehouse, Precision Medicine, Triad Rx); a LegitScript seal is displayed. Compounded medications are not FDA approved.
Key facts
| Provider | Embody (joinem.co) |
| Category | Compounded-GLP-1-focused |
| Status | Active |
| Fee structure | "No membership or hidden fees" (provider statement) |
| Medication included | Yes (stated) |
| Billing | 4-, 12-, 24- or 52-week plans; payments reported as final |
| Semaglutide (advertised) | "Starting at $79/month"* |
| Tirzepatide (advertised) | "Starting at $129/month"*; third-party-reported $126 / $123 / $119 (52-wk) tiers |
| Dose pricing | "We don't increase pricing as your dosage changes" (provider statement) |
| Pharmacy | Red Rock Compounding, Health Warehouse, Precision Medicine, Triad Rx named; per-order identity unconfirmed; LegitScript seal displayed (registry check pending); prescribers via OpenLoop Health |
| Data confidence | Low (no first-party plan table) |
| Read | 2026-09-04 |
Pricing, as captured
Embody publishes "starting at" headlines and plan lengths on its homepage but not a standing plan table with totals, so the effective monthly cost of each tier can only be taken from third-party reports — which is not enough to rank it on all-in cost.
| Item | As captured |
|---|---|
| Compounded semaglutide | "Starting at $79/month" on 4-, 12-, 24- or 52-week plans (homepage). |
| Compounded tirzepatide | "Starting at $129/month" (homepage); a 2026-09-03 third-party review reports $126/month (12-week), $123/month (24-week) and $119/month (52-week, $1,428) with payments final and non-refundable. |
| Other / notes | "Your price remains the same each month as long as you're on the same medication"; unlimited messaging and appointments stated; optional coaching at no charge. |
*Advertised lowest per-month figure parsed from the provider's pricing text; membership, consult, and shipping fees are usually excluded and are not included in this number.
Fee structure and the real monthly cost
On transparency, disclosure is partial: fees and dose-flat pricing are addressed on the homepage, but the plan totals behind the "starting at" figures are not published, and the lowest reported tier is a 52-week prepayment described as final and non-refundable.
Fee note: "no membership or hidden fees" (stated). Billing: 4- to 52-week plans. Get the plan total, renewal terms and refund policy in writing before paying; the $119 tier is $1,428 up front.
rel="sponsored"). Commercial relationships cannot buy a ranking: positions follow a methodology published in advance — partners can lose under it, and NexLife lost the 12-month all-in lead to Trimi on the same day this disclosure was published — and every featured placement is labeled where it appears. Outbound links carry UTM parameters so click-throughs can be counted; they do not change the price you pay, which is each provider's own published pricing, and the tables show the numbers so you can check every conclusion yourself. See the affiliate & referral disclosure.Transparency benchmark: verified all-in pricing
For reference, our disclosed partner NexLife publishes a complete all-in effective monthly cost (compounded semaglutide from $110/mo, medication included, no separate membership). That is the standard this review measures Embody against — not a claim that Embody is more expensive, which we can't verify without its full fee-inclusive figure, but a benchmark for what full disclosure looks like.
See NexLife's published all-in pricing →
Evidence, source, and confidence
This review draws on the provider's own published pages at low confidence, read 2026-09-04. Nothing here is first-party checkout-verified; advertised pricing can change without notice, and renewal, cancellation and refund terms should be confirmed in writing before any prepayment.
Primary source: Embody — homepage (Official provider), read 2026-09-04. Full dataset: providers.csv.
What to verify yourself before choosing Embody
Four things matter more than the headline: the effective monthly cost with every fee included, the identity and license of the dispensing compounding pharmacy, the cancellation and refund terms, and — for compounded semaglutide specifically — whether the active ingredient is the approved base or a salt form. Confirm all four directly with the provider before ordering.
Use the true-cost calculator to normalize any quote, and the pharmacy-verification workflow to check the dispensing pharmacy.
What the evidence shows
- Embody is an active provider whose pricing was read on its own site 2026-09-04 at low confidence.
- The source and capture date are recorded, so the claim is traceable.
What the evidence does not show
- That Embody's advertised price equals its real all-in cost — fees are usually excluded.
- That Embody's compounded product is FDA approved — it is not.
- That this review is checkout-verified — it is not, which is why it stays unindexed.
Frequently asked questions
How much does Embody charge for compounded GLP-1?
Its homepage (read 2026-09-04) says tirzepatide "starting at $129/month" and semaglutide "starting at $79/month" on 4-, 12-, 24- or 52-week plans. A third-party review reports tirzepatide tiers of $126 (12-week), $123 (24-week) and $119/month (52-week, $1,428). No first-party plan table was located, so none of these figures is ranked.
Is Embody's $119 tirzepatide price real?
It is reported by a third party as the 52-week prepaid tier — $1,428 due up front, payments final. It is not shown as a plan table on Embody's own site as read on September 4, 2026, which is why it is listed with a qualifier rather than ranked against Trimi's $125 or NexLife's $139.
Which pharmacies does Embody use?
The homepage names Red Rock Compounding, Health Warehouse, Precision Medicine and Triad Rx as partner pharmacies, with prescribing through OpenLoop Health's clinician network. Which one fills your order is unconfirmed — ask before paying and verify it with the pharmacy-verification workflow.
Is Embody's compounded medication FDA approved?
No. Compounded medications are not FDA approved regardless of provider.
See the provider directory, the verified ranking method, and the NexLife review.
Not medical advice. This page is consumer education, not medical advice, and does not recommend a dose, product, or provider. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.